Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and Beyond

David Calvin Goff1, Sadiya Sana Khan2, Donald Lloyd-Jones2

  • 1Division of Cardiovascular Sciences (D.C.G., G.S.W.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Circulation
|February 22, 2021
PubMed

Insights

Coronary heart disease mortality decline may be reversing, with heart failure deaths rising. A symposium reviewed progress since 1978 and discussed strategies to improve cardiovascular health.

Area of Science:

  • Cardiovascular Disease Epidemiology
  • Public Health Policy
  • Preventive Cardiology

Background:

  • The 1978 Bethesda Conference provided a framework for understanding declining coronary heart disease (CHD) mortality.
  • Recent trends suggest CHD mortality decline has stalled or reversed, with increasing heart failure (HF) mortality.
  • Advances in knowledge and treatment have not fully halted adverse cardiovascular disease (CVD) trends.

Purpose of the Study:

  • To commemorate the 40th anniversary of the 1978 Bethesda Conference.
  • To evaluate the outcomes of the 1978 conference and assess the current CVD landscape.
  • To identify opportunities for preserving and promoting cardiovascular health and preventing CVD.

Main Methods:

  • Convened the "Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40" symposium.
  • Discussed trends and projections in CVD, obesity, and diabetes.
  • Explored challenges and barriers to promoting cardiovascular health across the lifespan.

Main Results:

  • Overall CVD mortality rates are decelerating, but HF mortality is increasing.
  • Emerging epidemics of obesity and diabetes pose significant challenges.
  • A framework for early-life interventions and observational research was proposed.

Conclusions:

  • The trajectory of cardiovascular disease mortality is complex and requires renewed focus.
  • Interventions targeting early life, including in utero, are crucial for long-term cardiovascular health.
  • Addressing obesity and diabetes is essential for preventing future CVD.

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...